abstract |
The present invention provides compounds of formula 1 which are novel β 2 adrenergic receptor agonists: wherein R 1 -R 13 and w are any of the values described herein. The present invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with β 2 adrenergic receptor activity, methods of making such compounds, and intermediates useful in such preparations. . |